Hydrochloric Acid → 5-(4-Fluoro-phenyl)-4-oxo-1,4-dihydro-pyridine-3-carboxylic acid [3-fluoro-4-(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalen-4-yloxy)-phenyl]-amide

HRID 595137Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 595137
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:9](=[O:17])[C:10]([C:14]([OH:16])=O)=[CH:11][NH:12][CH:13]=2)=[CH:4][CH:3]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.[F:35][P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[NH2:51][C:52]1[CH:78]=[CH:77][C:55]([O:56][C:57]2[C:58]3[CH:59]=[C:60]4[O:76][CH2:75][CH2:74][O:73][CH2:72][CH2:71][O:70][CH2:69][CH2:68][O:67][C:61]4=[CH:62][C:63]=3[N:64]=[CH:65][N:66]=2)=[C:54](C)[CH:53]=1.Cl>CN(C=O)C>[F:35][C:54]1[CH:53]=[C:52]([NH:51][C:14]([C:10]2[C:9](=[O:17])[C:8]([C:5]3[CH:4]=[CH:3][C:2]([F:1])=[CH:7][CH:6]=3)=[CH:13][NH:12][CH:11]=2)=[O:16])[CH:78]=[CH:77][C:55]=1[O:56][C:57]1[C:58]2[CH:59]=[C:60]3[O:76][CH2:75][CH2:74][O:73][CH2:72][CH2:71][O:70][CH2:69][CH2:68][O:67][C:61]3=[CH:62][C:63]=2[N:64]=[CH:65][N:66]=1

Komponenten

7

Edukt 5

HCID 313Hydrochloric AcidHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 602042075-(4-Fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acidHCID 866848304-(4-Amino-2-Methyl-phenoxy)-7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalene

Produkt 1

HCID 566437095-(4-Fluoro-phenyl)-4-oxo-1,4-dihydro-pyridine-3-carboxylic acid [3-fluoro-4-(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalen-4-yloxy)-phenyl]-amideAusbeute 40 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

To a suspension of 5-(4-Fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid 8d (J. Med. Chem. 2008, 51, 5330-5341) (8.0 g, 34.3 mmol) in anhydrous DMF (56 ml) were added HATU (15.65 g, 41.2 mmol) and i-Pr2NEt (18 ml, 104 mmol) at ice bath temperature under nitrogen. The mixture turned into a clear solution after being stirred for 5 min. To the solution was added 4-(4-Amino-2-Methyl-phenoxy)-7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalene 7a (7.9 g, 32.5 mmol) slowly. The reaction mixture was stirred for 3 h at room temperature and was poured into aqueous 1N HCl solution. The solid that formed was filtered, washed with distilled water, and dried. The crude product was purified by silica gel chromatography, eluting with 1-5% of MeOH in CH2Cl2 to obtain 9a as a light-yellow solid (5.9 g, 40%), mp 188-190° C. HPLC purity 97%; 1HNMR (400 MHz, DMSO) δ 13.13 (s, 1H), 12.68 (br s, 1H), 8.62 (m, 2H), 7.97-8.12 (m, 2H), 8.04-7.99 (m, 2H), 7.78 (m, 1H), 7.69 (m, 2H), 7.42 (d, 2H), 7.21 (m, 2H), 4.35 (s, 4H), 3.87 (d, 4H), 3.62 (s, 4H). LC/MS Calcd for (M+H)′ 617.6. found 617.5.

Aufarbeitung

  1. stirringThe reaction mixture was stirred for 3 h at room temperature
  2. customThe solid that formed
  3. filtrationwas filtered
  4. washwashed with distilled water
  5. customdried
  6. customThe crude product was purified by silica gel chromatography
  7. washeluting with 1-5% of MeOH in CH2Cl2

Quellen und Nachweise

ORD-Eintrag
ord-c2906908c10b402a8da4e621d6543459
Quelldatensatz
uspto-grants-2016_01
Patentnummer
US09242991B2

Notizen zur Reaktion

Wird geladen…